Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

Kaiser Daily Global Health Policy ReportMalaria Search Results « » The Henry J. Kaiser Family Foundation

Malaria

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Health Aid Disbursement Generally Cost-Effective But Not Always Optimal, Study Shows

Health Affairs: Health Aid Is Allocated Efficiently, But Not Optimally: Insights From A Review Of Cost-Effectiveness Studies Eran Bendavid, assistant professor in the Department of Medicine at Stanford University, and colleagues “reviewed the literature for cost-effectiveness of interventions targeting five disease categories: HIV; malaria; tuberculosis; noncommunicable diseases; and maternal, newborn,…

Philanthropists, Business Leaders, Others Critical To Ending Malaria

Huffington Post U.K.: The World’s Greatest Minds Challenge Mankind’s Oldest Disease James Whiting, executive director of Malaria No More U.K. “…Brilliant business minds and entrepreneurial approaches to tackling malaria are in our DNA and paramount to our future work. 10 years ago Wall Street pioneer Ray Chambers co-founded Malaria No…

New Issue Of ‘Global Fund News Flash’ Available Online

Global Fund to Fight AIDS, Tuberculosis and Malaria: Global Fund News Flash The latest issue of the Global Fund News Flash discusses highlights from the recent Partnership Forum in Bangkok, Thailand, which “produced vibrant and stimulating discussions on strategies to end HIV, TB, and malaria as epidemics” (6/30).

2 U.S. Oil Companies, Equatorial Guinea Partner To Fund Malaria Vaccine Trials

Financial Times: Hopes rise for malaria vaccine as oil companies fund trials “Two U.S. oil companies are pouring millions of dollars into the trials of a promising malaria vaccine in Equatorial Guinea in a rare sign of foreign investors trying to help tackle one of Africa’s biggest health scourges. Marathon…

Blog Posts Highlight Research Into New Drugs For Malaria, Other Diseases

Global Health Technologies Coalition’s “Breakthroughs”: Research Roundup: a promising antimalarial and leishmaniasis vaccine, diagnostics for tuberculosis, and more Kat Kelley, GHTC’s senior program assistant, highlights recent news in global health research, including the development of an experimental antimalarial drug and a potential leishmaniasis vaccine, clinical trials for new tuberculosis diagnostic…

UCSF Receives $4.5M Donation For Innovative Malaria Research

SFGate: Entrepreneur gives UCSF $4.5 million to combat malaria “Billionaire Silicon Valley entrepreneur Sean Parker has given money for medical research, including allergies and cancer, and now has turned his attention to malaria with a $4.5 million gift to UCSF to tackle the global health issue. The Napster founder and…

The Guardian Examines Progress Made On MDG 6, Remaining Challenges

The Guardian: What is the Millennium Development Goal on HIV and malaria all about? “When the Millennium Development Goals (MDGs) were devised, AIDS, malaria, and tuberculosis killed approximately six million people each year. World leaders felt it was imperative to have a goal dedicated to tackling this deadly trio. ……